(Q33769931)

English

Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Salmonella enterica

0 references

Sujata M Bhavnani

6

object named as

Sujata M Bhavnani

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

Paul G Ambrose

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Brent M Booker

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Patrick F Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alan Forrest

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Julie Bullock

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Pamela Kelchlin

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1775-1781

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical pharmacodynamics of quinolones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Enteric fever treatment failures: a global concern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

4 July 2018

Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

30 October 2018

Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

30 October 2018

Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

30 October 2018

Age and gender effects on the pharmacokinetics of gatifloxacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

30 October 2018

Ciprofloxacin-resistant Salmonella typhi and treatment failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1087614

30 October 2018

Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15855495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/15855495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of fluoroquinolones in experimental models of endocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15855495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/15855495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-level resistance to fluoroquinolones among Salmonella and Shigella

1 reference

https://pubmed.ncbi.nlm.nih.gov/15855495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.5.1775-1781.2005

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33769931&oldid=2106956833"